Abstract
Drug treatment of chronic heart failure is undergoing continuous modifications according to the data of new trials. Treatment has to be adjusted to current guidelines. The state of the art of medical treatment of chronic heart failure is addressed in this report.
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Angiotensins / antagonists & inhibitors
-
Anti-Arrhythmia Agents / administration & dosage
-
Anti-Arrhythmia Agents / therapeutic use
-
Cardiotonic Agents / administration & dosage
-
Cardiotonic Agents / therapeutic use
-
Chronic Disease
-
Diuretics / administration & dosage
-
Diuretics / therapeutic use
-
Drug Therapy, Combination
-
Heart Failure / drug therapy*
-
Heart Failure / physiopathology
-
Humans
-
Mineralocorticoid Receptor Antagonists / administration & dosage
-
Mineralocorticoid Receptor Antagonists / therapeutic use
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Angiotensins
-
Anti-Arrhythmia Agents
-
Cardiotonic Agents
-
Diuretics
-
Mineralocorticoid Receptor Antagonists